Clinic does not promote, or endorse any specific medications or therapies
Of the injured patients, about 21% required heart surgery, and Van Norman recounts that many experienced disability and/or death. The FDA requested the withdrawal of the drugs in 1997 after more than 20,000 personal injury lawsuits and a $21 billion settlement with the manufacturer, Wyeth Pharmaceuticals
its use in the treatment of edema of congestive heart failure, nephrosis, and cirrhosis
The research-grade material supplied by Koi Peptides is synthesized independently for in vitro laboratory research only not formulated, packaged, or labeled for human use, not equivalent to or a substitute for any approved drug or cosmetic product, and not authorized for any human or veterinary indication